Letters, Testimony & Comments

Representative Matt Hudson Florida House of Representatives 402 South Monroe Street Tallahassee, FL 32399 Dear Representative Hudson...
February 1 2013
Biologics are complex medicines manufactured from living organisms. Unlike traditional “small molecule” drugs, biologics are...
January 24 2013
The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology trade association. BIO represents more than 1,...
January 24 2013
The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology trade association. BIO represents more than 1,...
January 24 2013
In December 2012, Virginia House Delegate John M. O'Bannon, III introduced the Interchangeable biosimilar biological products bill (H...
January 10 2013
February 22, 2012 Texas Health and Human Services Commission Attn: Stacey Johnston Policy Analyst Medicaid/Children’s Health...
March 1 2012
Economic Development and Jobs for the Michigan Bioscience Industry Michigan House and Senate Standings Committee on the Biosciences...
September 13 2011
Committee on Transportation New Hampshire State Senate Hearing on HB 374, banning corn-based ethanol as an additive to gasoline sold...
April 28 2011
Testimony of the Biotechnology Industry Organization (BIO) Hearing of the House Committee on Health, Education and Welfare April 13,...
April 13 2011
"An Act establishing procedures for sampling plants protected by patent or other intellectual property laws; requiring mediation of...
February 1 2011
Comments on the “Rule Requiring Use of Best Management Practices for Growing Crops to Minimize Cross Contamination” Dear...
December 14 2009
Re: Docket No. FDA-2008-D-0559, Draft Guidance for Industry on Process Validation: General Principles and Practices; Availability...
January 21 2009

Letters, Testimony & Comments

May 8 2013
BIO  urges Florida Governor Scott to sign House Bill 365 – a bill related to the substitution of biologic and biosimilar medicines – which recently passed out of the Legislature.
February 1 2013
BIO supports passage of Florida House Bill 365, which provides requirements for pharmacist to dispense substitute biological products that are determined to be interchangeable for prescribed biological product.
January 24 2013
To ensure transparency and communication between patients and their treatment teams, BIO believes that certain safeguards should guide substitution policies for interchangeable biologics under state law as well.
January 24 2013
The policies outlined in Senate Bill 2190 align with all five of BIO’s Principles on Biologic Product Substitution and we therefore support its passage.
January 24 2013
BIO opposes the proposal to subject certain cancer therapies to prior authorization measures under Senate Bill 2066.

Press Releases

June 7 2013
Oregon Governor John Kitzhaber signed legislation on Thursday, June 6 designed to address the regulatory issues related to the interchangeability of biological medicines.
June 5 2013
House Bill 365, signed by Governor Rick Scott, contains four of BIO’s five principles on biologic product substitution
June 3 2013
Florida's repeal of the state Renewable Fuel Standard could chill investment, innovation and job creation within the state's biotechnology industry.
April 23 2013
The Biotechnology Industry Organization (BIO) released its “Bioscience Economic Development: Legislative Priorities, Best Practices, and Return On Investment” report today at the 2013 BIO International Convention.  
April 3 2013
The Biotechnology Industry Organization (BIO) and BioFlorida commend the Florida Senate Committee on Health Policy for passage of Senate Bill 732 out of committee.